Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-24 | 166.62 | 150.48 | 10.66p | 18.6 | 0.2 | +103% | 10.08p | 0.0% |
31-Mar-25 | 376.53 | 328.67 | 13.02p | 15.3 | 0.7 | +22% | 12.06p | 0.0% |
31-Mar-26 | 387.58 | 337.31 | 13.46p | 14.8 | 4.4 | +3% | 12.45p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
---|---|---|---|---|---|---|
Revenue (£m) | ||||||
31-Mar-2025 | 376 | 376 | 376 | 167 | 169 | 163 |
31-Mar-2026 | 388 | 388 | 388 | 178 | 178 | n/a |
Earnings | ||||||
31-Mar-2025 | 13.02p | 13.02p | 13.02p | 10.81p | 10.96p | 10.96p |
31-Mar-2026 | 13.46p | 13.46p | 13.46p | 11.32p | 11.41p | n/a |
Dividend | ||||||
31-Mar-2025 | 12.06p | 12.06p | 12.06p | 10.07p | 10.15p | 10.03p |
31-Mar-2026 | 12.45p | 12.45p | 12.45p | 10.28p | 10.48p | n/a |
Recommendations | ||||||
Strong Buy | 4 | 4 | 4 | 1 | 2 | 2 |
Buy | 5 | 5 | 5 | 1 | 4 | 3 |
Neutral | 4 | 4 | 4 | 7 | 6 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
No. of Brokers | 13 | 13 | 13 | 9 | 12 | 14 |
Average Rec | 7.50 | 7.50 | 7.50 | 5.83 | 6.67 | 5.89 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 202.40p |
Change Today | 3.60p |
% Change | 1.81 % |
52 Week High | 205.60 |
52 Week Low | 156.40 |
Volume | 3,553,785 |
Shares Issued | 2,040.57m |
Market Cap | £4,130.11m |
Beta | 0.01 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 5 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 13 |
Latest | Previous | |
---|---|---|
3rd Interim | 2nd Interim | |
Ex-Div | 29-Feb-24 | 30-Nov-23 |
Paid | 08-Apr-24 | 11-Jan-24 |
Amount | 2.40p | 2.40p |
Time | Volume / Share Price |
16:19 | 1,457 @ 202.60p |
16:18 | 1,139 @ 202.60p |
16:17 | 748 @ 202.60p |
16:17 | 1,811 @ 202.40p |
16:17 | 445 @ 202.40p |
Finance Director | Martin McGann |
CEO | Andrew Jones |
Chair | Alistair Elliott |
You are here: research